Mannitol Demo

Mannitol, the active ingredient in Mannitol Demo, is a osmotic diuretic presented as a unknown/unknown for Intravenous use. It treats increased intracranial pressure, acute renal failure and oliguria in hospital settings. It is administered under medical supervision and is indicated for rapid reduction of elevated intracranial pressure, facilitation of diuresis in acute kidney injury, and promotion of urine output in oliguria.

GNH USA supplies Mannitol Demo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company follows Good Distribution Practice standards, ensuring product integrity and providing regulatory documentation for import and clinical use.

Mannitol is an osmotic diuretic used in conditions where reduction of fluid volume or pressure is required. - Increased intracranial pressure: draws water from brain tissue into the vascular space, decreasing cerebral edema and lowering intracranial pressure. - Acute renal failure: creates an osmotic gradient that enhances renal water excretion, supporting diuresis in patients with impaired kidney function. - Oliguria: increases urine output by osmotic pulling of water into renal tubules, helping to restore adequate diuresis.

Mannitol may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache during or after infusion. - Nausea: transient nausea or vomiting. - Electrolyte imbalance: mild changes in sodium or potassium levels. - Diuresis-related volume depletion: increased urine output leading to thirst.

Serious or Rare Side Effects: - Renal failure: acute tubular necrosis in susceptible patients. - Pulmonary edema: fluid overload causing respiratory distress. - Severe electrolyte disturbances: hypernatremia or hyponatremia. - Anaphylactoid reaction: rare hypersensitivity with rash, hypotension.

Before using Mannitol, clinicians should consider several precautionary measures to minimize risks. - Assess renal function: evaluate creatinine clearance before initiation. - Monitor fluid balance: track input and output to avoid volume overload or depletion. - Check electrolytes: regularly measure serum sodium, potassium, and osmolality. - Use caution in cardiac disease: patients with heart failure may be sensitive to rapid volume shifts. - Avoid in anuria: contraindicated when urine output is absent. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss and dehydration. - Lithium: increased risk of lithium toxicity due to altered renal clearance. - Antihypertensives: additive hypotensive effect when combined with vasodilators.

Moderate Interactions (Monitor Closely): - Aminoglycosides: potential for enhanced nephrotoxicity. - ACE inhibitors/ARBs: monitor renal function and potassium levels. - Insulin: osmotic shifts may affect glucose control.